Chimmitecan is a compound with antineoplastic activity, characterized as a pentacyclic heterocyclic structure containing multiple aromatic rings and polar functional groups. Its chemical identity is established from structural data and documented as an active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 185425-25-6
Topotecan hydrochloride
pharmaceutical raw material
Topotecan
pharmaceutical raw material
Ixabepilone
pharmaceutical raw material
Duocarmycin DM free base
pharmaceutical raw material
Alectinib hydrochloride
pharmaceutical raw material
8-azaguanine
pharmaceutical raw material
(RS)-salbutamol
pharmaceutical raw material
Rucaparib camsylate
pharmaceutical raw material
(19S)-19-ethyl-7,19-dihydroxy-8-prop-2-enyl-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
AXXPNDLHTNUMIK-QHCPKHFHSA-N
CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CC=C)O)N=C4C3=C2)O